New rapid test for identifying bacteremia in ICU patients
Evaluation of the Performance of a New Rapid Bacteremia Test in the Intensive Care Patient
This study tests a new quick blood test to see if it can help ICU patients with infections get the right antibiotics faster than the usual method.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 110 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Pessac) |
| Trial ID | NCT06241248 on ClinicalTrials.gov |
What this trial studies
This study evaluates a new rapid diagnostic test for bacteremia developed by OCEAN Dx, which aims to identify the presence of bacteria in the blood of intensive care unit patients within a few hours, compared to the traditional blood culture method that takes 48 to 72 hours. The study focuses on patients over 18 years old who are admitted to the ICU with suspected or documented infections. By quickly identifying the pathogen responsible for sepsis, the goal is to facilitate timely and appropriate antibiotic therapy, potentially improving patient outcomes. The performance of this rapid test will be assessed against standard blood culture techniques.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old admitted to an ICU with suspected or documented infections requiring blood cultures.
Not a fit: Patients under 18 years of age, pregnant or breastfeeding women, and those not affiliated with a social security regime may not benefit from this study.
Why it matters
Potential benefit: If successful, this test could significantly reduce the time to appropriate antibiotic treatment for patients with sepsis, potentially lowering mortality rates.
How similar studies have performed: Other studies have explored rapid diagnostic tests for sepsis, showing promising results, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age admitted to an intensive care unit (ICU) with a suspected or documented infection requiring blood cultures. Exclusion Criteria: * Patient under 18 years of age * Pregnant or breastfeeding woman * Patient of legal age, under guardianship or deprived of liberty * Not affiliated to a social security regime or not benefiting from such a regime.
Where this trial is running
Pessac
- Hopital Haut-Lévêque — Pessac, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.